High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

Abstract:

:High-dose cyclophosphamide, without stem cell rescue, has been used successfully to treat aplastic anemia and other autoimmune disorders. To determine the safety and efficacy of high-dose cyclophosphamide among patients with severe refractory autoimmune hemolytic anemia, we treated 9 patients with cyclophosphamide (50 mg. kg(-1). d(-1) for 4 days) who had failed a median of 3 (range, 1-7) other treatments. The median hemoglobin before treatment was 6.7 g/dL (range, 5-10 g/dL). The median time to reach an absolute neutrophil count of 500/microL or greater was 16 days (range, 12-18 days). Six patients achieved complete remission (normal untransfused hemoglobin for age and sex), and none have relapsed after a median follow-up of 15 months (range, 4-29 months). Three patients achieved and continue in partial remission (hemoglobin at least 10 g/dL without transfusion support). High-dose cyclophosphamide was well tolerated and induced durable remissions in patients with severe refractory autoimmune hemolytic anemia.

journal_name

Blood

journal_title

Blood

authors

Moyo VM,Smith D,Brodsky I,Crilley P,Jones RJ,Brodsky RA

doi

10.1182/blood-2002-01-0087

subject

Has Abstract

pub_date

2002-07-15 00:00:00

pages

704-6

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

100

pub_type

临床试验,杂志文章

相关文献

BLOOD文献大全
  • Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging.

    abstract::DNA methylation plays an important role in the self-renewal of hematopoietic stem cells and in the commitment to the lymphoid or myeloid lineages. Using purified CD34⁺ hematopoietic progenitor cells and differentiated myeloid cell populations from the same human samples, we obtained detailed methylation profiles at di...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-331926

    authors: Bocker MT,Hellwig I,Breiling A,Eckstein V,Ho AD,Lyko F

    更新日期:2011-05-12 00:00:00

  • Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.

    abstract::Mutations in PIEZO1 are the primary cause of hereditary xerocytosis, a clinically heterogeneous, dominantly inherited disorder of erythrocyte dehydration. We used next-generation sequencing-based techniques to identify PIEZO1 mutations in individuals from 9 kindreds referred with suspected hereditary xerocytosis (HX) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-05-786004

    authors: Glogowska E,Schneider ER,Maksimova Y,Schulz VP,Lezon-Geyda K,Wu J,Radhakrishnan K,Keel SB,Mahoney D,Freidmann AM,Altura RA,Gracheva EO,Bagriantsev SN,Kalfa TA,Gallagher PG

    更新日期:2017-10-19 00:00:00

  • Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses.

    abstract::We previously reported the characterization of human osteoclast-associated receptor (hOSCAR), a novel Fc receptor gamma-chain (FcRgamma)-associated receptor expressed by myeloid cells. Here we show that ligation of hOSCAR by specific antibodies promotes dendritic cell (DC) survival by an extracellular signal-regulated...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2809

    authors: Merck E,de Saint-Vis B,Scuiller M,Gaillard C,Caux C,Trinchieri G,Bates EE

    更新日期:2005-05-01 00:00:00

  • How I treat steroid-refractory acute graft-versus-host disease.

    abstract::Steroid-resistant or steroid-refractory acute graft-versus-host disease (SR-aGVHD) poses one of the most vexing challenges faced by providers who care for patients after allogeneic hematopoietic cell transplantation. For the past 4 decades, research in the field has been driven by the premise that persistent graft-ver...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000960

    authors: Martin PJ

    更新日期:2020-05-07 00:00:00

  • The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.

    abstract::Anaplastic large cell lymphoma represents a subset of neoplasms caused by translocations that juxtapose the anaplastic lymphoma kinase (ALK) to dimerization partners. The constitutive activation of ALK fusion proteins leads to cellular transformation through a complex signaling network. To elucidate the ALK pathways s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161018

    authors: Boccalatte FE,Voena C,Riganti C,Bosia A,D'Amico L,Riera L,Cheng M,Ruggeri B,Jensen ON,Goss VL,Lee K,Nardone J,Rush J,Polakiewicz RD,Comb MJ,Chiarle R,Inghirami G

    更新日期:2009-03-19 00:00:00

  • Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes.

    abstract::Plasmodium falciparum-infected erythrocytes (parasitized red blood cells [PRBCs]) can adhere to uninfected erythrocytes (RBCs) to form rosettes, and adhere to the endothelial cell (EC) surface antigen CD36. These adherence phenomena have previously been considered quite different. We show that anti-CD36 monoclonal ant...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Handunnetti SM,van Schravendijk MR,Hasler T,Barnwell JW,Greenwalt DE,Howard RJ

    更新日期:1992-10-15 00:00:00

  • Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.

    abstract::Because of continuous blood transfusions, thalassemia patients are subjected to peroxidative tissue injury by the secondary iron overload. In accordance, analysis of serum from 42 beta-thalassemia patients, aged 4 to 40 years, showed that the mean concentrations of conjugated diene lipid hydroperoxides (CD), lipoperox...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Livrea MA,Tesoriere L,Pintaudi AM,Calabrese A,Maggio A,Freisleben HJ,D'Arpa D,D'Anna R,Bongiorno A

    更新日期:1996-11-01 00:00:00

  • Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

    abstract::Serum cytokines and chemokines may reflect tumor biology and host response in follicular lymphoma (FL). To determine whether the addition of these biological factors may further refine prognostication, 30 cytokines and chemokines were measured in pretreatment serum specimens from newly diagnosed FL patients (n = 209) ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2014-06-583369

    authors: Mir MA,Maurer MJ,Ziesmer SC,Slager SL,Habermann T,Macon WR,Link BK,Syrbu S,Witzig T,Friedberg JW,Press O,LeBlanc M,Cerhan JR,Novak A,Ansell SM

    更新日期:2015-02-05 00:00:00

  • Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.

    abstract::The most common chromosomal abnormality of infant acute lymphoblastic leukemia (ALL) is the t(4;11)(q21;q23) that gives rise to the MLL/AF4 fusion gene. Leukemic blasts expressing MLL/AF4 are arrested at an early progenitor stage with lymphoid or monocytoid characteristics. A novel B-lineage ALL cell line termed B-lin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.12.3398

    authors: Bertrand FE,Vogtenhuber C,Shah N,LeBien TW

    更新日期:2001-12-01 00:00:00

  • Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage.

    abstract::We demonstrated that Flk-1(+) cells derived from mouse embryonic stem (ES) cells can differentiate into both endothelial cells (ECs) and mural cells (MCs) to suffice as vascular progenitor cells (VPCs). In the present study, we investigated the importance of the stage of ES cell differentiation on effective participat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1877

    authors: Yurugi-Kobayashi T,Itoh H,Yamashita J,Yamahara K,Hirai H,Kobayashi T,Ogawa M,Nishikawa S,Nishikawa S,Nakao K

    更新日期:2003-04-01 00:00:00

  • Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

    abstract::Hodgkin- and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin lymphomas (cHL) of 40 patients comprising 8 lymphocyte-rich (cHL-LR), 16 nodular sclerosis (cHL-NS), 15 mixed-cellularity (cHL-MC), and 2 lymphocyte-depletion (cHL-LD) subtypes were analyzed by comparative genomic hybridization for recurr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1381

    authors: Joos S,Menz CK,Wrobel G,Siebert R,Gesk S,Ohl S,Mechtersheimer G,Trümper L,Möller P,Lichter P,Barth TF

    更新日期:2002-02-15 00:00:00

  • How I treat venous thromboembolism in patients with cancer.

    abstract::Venous thromboembolism (VTE) is a frequent complication in cancer patients and represents an important cause of morbidity and mortality. Especially in patients who have a poor life expectancy, preventing death from pulmonary embolism is the mainstay of treatment. Critically ill patients should promptly be administered...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1508

    authors: Prandoni P

    更新日期:2005-12-15 00:00:00

  • T cell receptor (alpha, beta, gamma) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells.

    abstract::The large granular lymphocyte (LGL) population, which effects a natural killer (NK) function, consists of cells whose lineage derivation has not been clearly established on the basis of phenotypic and functional properties. To clarify the relationship of LGL/NK cells to T cells we studied patterns of rearrangement and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pelicci PG,Allavena P,Subar M,Rambaldi A,Pirelli A,Di Bello M,Barbui T,Knowles DM 2nd,Dalla-Favera R,Mantovani A

    更新日期:1987-11-01 00:00:00

  • IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo.

    abstract::Interleukin 21 (IL-21) is a member of the common gamma-chain family of cytokines, which influence a broad spectrum of immunologic responses. A number of studies have examined the function of IL-21, but its specific role in Th1/Th2-cell differentiation and related effector responses remains to be clarified. Thus, we ge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021600

    authors: Fröhlich A,Marsland BJ,Sonderegger I,Kurrer M,Hodge MR,Harris NL,Kopf M

    更新日期:2007-03-01 00:00:00

  • A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene.

    abstract::Hypoxia is a strong stimulus for the transcription of a set of genes, including erythropoietin and vascular endothelial growth factor. Here we report on the cloning, functional significance, and expression of a complementary DNA (cDNA) that is involved in hypoxia-mediated expression of these 2 genes. The full-length c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gupta M,Mungai PT,Goldwasser E

    更新日期:2000-07-15 00:00:00

  • Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.

    abstract::The regulation of plasmin generation on cell surfaces is of critical importance in the control of vascular homeostasis. Cell-derived microparticles participate in the dissemination of biological activities. However, their capacity to promote plasmin generation has not been documented. In this study, we show that endot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-069997

    authors: Lacroix R,Sabatier F,Mialhe A,Basire A,Pannell R,Borghi H,Robert S,Lamy E,Plawinski L,Camoin-Jau L,Gurewich V,Angles-Cano E,Dignat-George F

    更新日期:2007-10-01 00:00:00

  • Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.

    abstract::Autologous stem cell transplantation (ASCT) is considered the gold standard in the frontline therapy of younger patients with multiple myeloma because it results in higher complete remission (CR) rates and longer event-free survival than conventional chemotherapy. The greatest benefit from ASCT is obtained in patients...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2009-08-238196

    authors: Bladé J,Rosiñol L,Cibeira MT,Rovira M,Carreras E

    更新日期:2010-05-06 00:00:00

  • Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).

    abstract::In The Netherlands from July 1988 to October 1991, children (0 to 16 years of age) with de novo acute lymphoblastic leukemia (ALL) were treated according to protocol ALL-7 of the Dutch Childhood Leukemia Study Group (DCLSG). In this protocol, chemotherapy and treatment stratification were identical to the ALL-BFM-86 p...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Kamps WA,Bökkerink JP,Hählen K,Hermans J,Riehm H,Gadner H,Schrappe M,Slater R,van den Berg-de Ruiter E,Smets LA,de Vaan GA,Weening RS,van Weerden JF,van Wering ER,den der Does-van den Berg A

    更新日期:1999-08-15 00:00:00

  • Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.

    abstract::Rh(o)(D) immune globulin intravenous (anti-D IGIV) was licensed by the United States Food and Drug Administration (FDA) in March 1995 to treat patients with immune thrombocytopenic purpura (ITP). Anti-D IGIV induces extravascular hemolysis, an expected adverse reaction that is consistent with the presumed mechanism of...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Gaines AR

    更新日期:2000-04-15 00:00:00

  • Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome.

    abstract::A patient with severe anemia, reticulocytopenia, and erythroid hyperplasia of the bone marrow developed fatal acute nonlymphocytic leukemia after 3 yr. A Philadelphia chromosome with the typical 9/22 translocation t(9q +;22q-) was identified by banding techniques in a small number of bone marrow cells throughout the p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roth DG,Richman CM,Rowley JD

    更新日期:1980-08-01 00:00:00

  • Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

    abstract::The transcription factor nuclear factor-kappaB (NF-kappaB) confers significant survival potential in a variety of tumors. Several established or novel anti-multiple myeloma (anti-MM) agents, such as dexamethasone, thalidomide, and proteasome inhibitors (PS-341), inhibit NF-kappaB activity as part of their diverse acti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.11.4079

    authors: Mitsiades N,Mitsiades CS,Poulaki V,Chauhan D,Richardson PG,Hideshima T,Munshi N,Treon SP,Anderson KC

    更新日期:2002-06-01 00:00:00

  • Altered factor VII activity in hemophilia.

    abstract::Factor VII levels have been studied in hemophilia A and B plasmas and normal controls in a controlled, prospective study. Three assay methods were used: a standard clotting assay (FVIIc-A); a modified clotting assay (FVIIc-B) (Seligsohn et al, Blood 52:978-988, 1978); and a coupled amidolytic assay. By the FVIIc-B ass...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miller BC,Hultin MB,Jesty J

    更新日期:1985-04-01 00:00:00

  • TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.

    abstract::Cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs) are synthetic ODNs with unmethylated DNA sequences that mimic viral and bacterial DNA and protect against infectious agents and tumor challenge. We show that CpG ODNs markedly accelerated graft-versus-host disease (GVHD) lethality by Toll-like receptor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-113670

    authors: Taylor PA,Ehrhardt MJ,Lees CJ,Panoskaltsis-Mortari A,Krieg AM,Sharpe AH,Murphy WJ,Serody JS,Hemmi H,Akira S,Levy RB,Blazar BR

    更新日期:2008-10-15 00:00:00

  • Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.

    abstract::Marginal zone B-cell lymphoma (MZL) is a recently individualized lymphoma that encompasses mucosa-associated lymphoid tissue (MALT) lymphoma, splenic lymphoma with or without villous lymphocytes, and nodal lymphoma with or without monocytoid B-cells. If the clinical description and outcome of MALT lymphoma is well kno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berger F,Felman P,Thieblemont C,Pradier T,Baseggio L,Bryon PA,Salles G,Callet-Bauchu E,Coiffier B

    更新日期:2000-03-15 00:00:00

  • Transcript profiling of human platelets using microarray and serial analysis of gene expression.

    abstract::Human platelets are anucleate blood cells that retain cytoplasmic mRNA and maintain functionally intact protein translational capabilities. We have adapted complementary techniques of microarray and serial analysis of gene expression (SAGE) for genetic profiling of highly purified human blood platelets. Microarray ana...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2797

    authors: Gnatenko DV,Dunn JJ,McCorkle SR,Weissmann D,Perrotta PL,Bahou WF

    更新日期:2003-03-15 00:00:00

  • Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune disease with a complex pathogenesis. As in many B cell-related autoimmune diseases, rituximab (RTX) has been shown to increase platelet counts in some ITP patients. From an immunologic standpoint, the mode of action of RTX and the reasons underlying its limited efficacy h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-344051

    authors: Audia S,Samson M,Guy J,Janikashvili N,Fraszczak J,Trad M,Ciudad M,Leguy V,Berthier S,Petrella T,Aho-Glélé S,Martin L,Maynadié M,Lorcerie B,Rat P,Cheynel N,Katsanis E,Larmonier N,Bonnotte B

    更新日期:2011-10-20 00:00:00

  • Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia.

    abstract::Coculture of nurse-like cells (NLCs) with chronic lymphocytic leukemia (CLL) cells induced leukemia cell phosphorylation of STAT3 (pSTAT3), which could be blocked by anti-Wnt5a antibodies or the anti-ROR1 monoclonal antibody, cirmtuzumab. Time-course studies revealed Wnt5a could induce activation of NF-κB within 30 mi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001366

    authors: Chen Y,Chen L,Yu J,Ghia EM,Choi MY,Zhang L,Zhang S,Sanchez-Lopez E,Widhopf GF 2nd,Messer K,Rassenti LZ,Jamieson C,Kipps TJ

    更新日期:2019-09-26 00:00:00

  • VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

    abstract::In human follicular lymphoma the t(14; 18) chromosome translocation activates the antiapoptotic oncogene Bcl2 by linking it to the immunoglobulin heavy chain (IGH) locus. Transgenic mice expressing Bcl2 controlled by an Igh enhancer (E mu) do not develop follicular lymphoma, although they do have an increased incidenc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2469

    authors: Egle A,Harris AW,Bath ML,O'Reilly L,Cory S

    更新日期:2004-03-15 00:00:00

  • Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone.

    abstract::Variations within proteasome β (PSMB) genes, which encode the β subunits of the 20S proteasome, may affect proteasome function, assembly, and/or binding of proteasome inhibitors. To investigate the potential association between PSMB gene variants and treatment-emergent resistance to bortezomib and/or long-term outcome...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2012-05-426924

    authors: Lichter DI,Danaee H,Pickard MD,Tayber O,Sintchak M,Shi H,Richardson PG,Cavenagh J,Bladé J,Façon T,Niesvizky R,Alsina M,Dalton W,Sonneveld P,Lonial S,van de Velde H,Ricci D,Esseltine DL,Trepicchio WL,Mulligan G,And

    更新日期:2012-11-29 00:00:00

  • Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

    abstract::Sixteen patients treated by allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) were evaluated by the polymerase chain reaction (PCR) for bcr/abl-specific RNA transcripts at various time points after BMT. In reconstitution experiments, one CML cell per million normal mononuclear cells c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roth MS,Antin JH,Bingham EL,Ginsburg D

    更新日期:1989-08-01 00:00:00